Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine TAP blocks for pain after C-section
NCT02893423Terminated
- Sponsor
- Maimonides Medical Center
- Start
- Jan 2013
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in postoperative pain, sponsored by Maimonides Medical Center. Primary endpoint: Visual Analog Scale at 48 hours. Started Jan 2013; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02893423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02893423.